Editorially Independent content supported with advertising by Genentech
Scott Walter, MD, MSc
Show Description +
When a treatment-naïve patient with advanced bilateral DME presented to the clinic, Scott Walter, MD, MSc, treated one eye with faricimab (Vabysmo, Genentech/Roche) and the other eye with ranibizumab (Lucentis, Genentech). What did he find when comparing responses to treatment based on fluorescein angiography results?
Posted: 8/30/2024
Scott Walter, MD, MSc
When a treatment-naïve patient with advanced bilateral DME presented to the clinic, Scott Walter, MD, MSc, treated one eye with faricimab (Vabysmo, Genentech/Roche) and the other eye with ranibizumab (Lucentis, Genentech). What did he find when comparing responses to treatment based on fluorescein angiography results?
Posted: 8/30/2024
Please log in to leave a comment.